HOW DOES  PBC AFFECT THE BILE DUCTS

                   Article from the Bare Facts Newsletter
                    produced by The PBC  Foundation UK

The liver is a unique organ in the body, on the one hand, it appears to be very complex, performing literally hundred of functions related to making substances that the body needs such as (blood proteins), and breaking down unwanted substances so that the body can get rid of them (such as bilirubin, the chemical responsible for jaundice in liver disease, formed as a result of the re-processing of haemoglobin from red blood cells).

On the other hand, the liver is very simple, consisting  of millions of identical liver cells (hepatocytes), each of which carries out all the functions of the liver. Because one of the important functions of the liver is to clear toxic by products present in the blood, it has a waste outflow system, the bile duct. This allows these unwanted substances to drain out into the bowel.

Blood, therefore, enters the liver (via both an artery-the hepaticartery, which supplies oxygen rich  blood from the lungs via the leftside of the heart-and, uniquely in the case of the liver, a vein called the portal vein-which brings blood rich in absorbed food products from the bowel) is treated by the hepatocytes and, now rich in new proteins, etc made by
the hepatocytes, drains out and back to the right side of  the heart via another vein, called the hepatic vein.

The unwanted products from  the blood are meanwile "treated by the hepatocytes and expelled into a network  of tiny channels (bile canaliculi) which, like small streams at the start of a river  system, join together to form progressively larger bile ducts (small rivers) which then go on to join together to eventually form the bile duct (a river) which drains into the bowel (an estuary).

                   In PBC..............

The smallest bile ducts (the streams in my river analogy) become damaged, narrowed and eventually blocked preventing the normal flow of bile out of the liver.  The damage to the bile duct lining cells appears to be caused by the bodies own immune system which, for reasons that are at present unclear (although  the subject of much scientific research), attacks the cells as if they were infected or foreign to the body and ultimately destroys them.  In the earliest stages of PBC (when patients may have anti-mitochondrial antibodies -AMA, the characteristic  blood antibody which is closely linked with PBC but normal  liver blood tests) this damage to the bile duct cells can be  quite active. Later on in the disease, when there are few bile ducts left, this  immune attack may burn itself out.

Failure of bile to flow freely out of  the liver appears to have a number of consequences.  Firstly, bile salts, instead of being able to leave the liver in the bile, build up within it. Bile salts, although not part of the toxic waste being expelled from the body in bile (in fact, they are hitching a ride in the bile in order to get to the bowel where they may help with the absorption of fat in the diet), are toxic to the liver cells and may cause further secondary damage to them. This build-up of bile salts means that damage to the liver may go on even if the immune system has stopped attacking the bile duct cells, and it is likely that this secondary damage plays a very significant role in the progression of PBC to Stage 4.

Secondly, the build-up of other toxins in the liver may lead to the typical symptoms of PBC, namely tiredness and itching. Thirdly,  failure of bile salts to get into the bile and hence the bowel may prevent the normal absorption of fat to the diet which may in turncontribute to the weight loss, loose bowels and crampy abdominal pain seen in many patients. 

Finally, failure to absorb fat soluble vitamins from the diet (if you can't absorb fat you can't absorb the vitamins dissolved in it) can contribute to, amongst other things  bone disease  in PBC.

              Many questions remain to be answered.

           a.) Why does this whole process start,
                and why does  it pick the patients it does?

          b.) Why does the  disease progress in some patients 
                whilst the majority remain with stable mild disease 
                for many years?

          c.) What is the  precise link between the damage to
                bile ducts and the symptoms of PBC?

              All these questions are the subject of scientific
             research currently being performed in the UK and
             elsewhere in the world. In the next edition  * of this
             column, I hope to explain how our approach to the
             treatment of PBC results from our understanding of 
             this disease process.
 

              MedicalAdviser  Dr David Jones Freeman Hospital
              Newcastle  UK
              *  The  Bare Facts Newsletter UK

gback.jpg
ghome.jpg

gnext.jpg